Scott Moore explores China’s trajectory in the global biotechnology sector. When the United States has been the dominant worldwide participant in producing and commercializing biotechnology for decades, China is set to be a number one player in biotechnology and is also investing seriously from the sector. Moore argues that, whilst the U.S. is pr